teriflunomide zentiva 14 mg apvalkotās tabletes
zentiva, k.s., czech republic - teriflunomīds - apvalkotā tablete - 14 mg
meliterix 14 mg apvalkotās tabletes
norameda uab, lithuania - teriflunomīds - apvalkotā tablete - 14 mg
tibsovo
les laboratoires servier - ivosidenib - leukemia, myeloid, acute; cholangiocarcinoma - antineoplastiski līdzekļi - tibsovo in combination with azacitidine is indicated for the treatment of adult patients with newly diagnosed acute myeloid leukaemia (aml) with an isocitrate dehydrogenase-1 (idh1) r132 mutation who are not eligible to receive standard induction chemotherapy (see section 5. tibsovo monotherapy is indicated for the treatment of adult patients with locally advanced or metastatic cholangiocarcinoma with an idh1 r132 mutation who were previously treated by at least one prior line of systemic therapy.
cefepime mip 2 g pulveris injekciju/infūziju šķīduma pagatavošanai
mip pharma gmbh, germany - cefepīms - pulveris injekciju/infūziju šķīduma pagatavošanai - 2 g
cefepime mip 1 g pulveris injekciju/infūziju šķīduma pagatavošanai
mip pharma gmbh, germany - cefepīms - pulveris injekciju/infūziju šķīduma pagatavošanai - 1 g
medoclav forte 250 mg/62,5 mg/5 ml pulveris iekšķīgi lietojamās suspensijas pagatavošanai
medochemie ltd., cyprus - amoxicillinum, skābes clavulanicum - pulveris iekšķīgi lietojamas suspensijas pagatavošanai - 250 mg/62,5 mg/5 ml
medoclav 125 mg/31,25 mg/5 ml pulveris iekšķīgi lietojamās suspensijas pagatavošanai
medochemie ltd., cyprus - amoxicillinum, skābes clavulanicum - pulveris iekšķīgi lietojamas suspensijas pagatavošanai - 125 mg/31,25 mg/5 ml
magnija sulfāts-kalceks 250 mg/ml šķīdums injekcijām
kalceks, a/s, latvia - magnija sulfas - Šķīdums injekcijām - 250 mg/ml
sanoral hct 40 mg/10 mg/25 mg apvalkotās tabletes
menarini international operations luxembourg s.a., luxembourg - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - apvalkotā tablete - 40 mg/10 mg/25 mg
sanoral hct 40 mg/5 mg/25 mg apvalkotās tabletes
menarini international operations luxembourg s.a., luxembourg - olmesartanum medoxomilum, amlodipinum, hydrochlorothiazidum - apvalkotā tablete - 40 mg/5 mg/25 mg